Advertisement

Topics

Combination Controversies: Checkpoint Inhibition Alone or in Combination for the Treatment of Melanoma?

11:00 EDT 15 May 2018 | Cancer Networks

In this review, we highlight prospective data on checkpoint inhibition alone and in combination, discuss data regarding the efficacy and toxicity of combination therapy, and identify clinical scenarios that may favor treatment with combination therapy.

Original Article: Combination Controversies: Checkpoint Inhibition Alone or in Combination for the Treatment of Melanoma?

NEXT ARTICLE

More From BioPortfolio on "Combination Controversies: Checkpoint Inhibition Alone or in Combination for the Treatment of Melanoma?"

Advertisement
Quick Search
Advertisement
Advertisement